FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086646 [Registered on: 09/05/2025] Trial Registered Prospectively
Last Modified On: 09/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A special membrane used to collect samples from the eye surface to test for corneal ulcers 
Scientific Title of Study   Corneal Impression Membrane (CIM) Sampling for Microbial Keratitis Diagnosis 
Trial Acronym  CIMS 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Josephine Christy 
Designation  Head of the Department, Cornea 
Affiliation  Aravind Eye Hospital 
Address  Room No.25, Department of Cornea, Aravind Eye Hospital, Thavallakuppam

Pondicherry
PONDICHERRY
605007
India 
Phone  04132619100  
Fax    
Email  josephine@aravind.org  
 
Details of Contact Person
Scientific Query
 
Name  Josephine Christy 
Designation  Head of the Department, Cornea 
Affiliation  Aravind Eye Hospital 
Address  Room No.25, Department of Cornea, Aravind Eye Hospital, Thavallakuppam

Pondicherry
PONDICHERRY
605007
India 
Phone  9994549584  
Fax    
Email  josephine@aravind.org  
 
Details of Contact Person
Public Query
 
Name  Josephine Christy 
Designation  Head of the Department, Cornea 
Affiliation  Aravind Eye Hospital 
Address  Room No.25, Department of Cornea, Aravind Eye Hospital, Thavallakuppam

Pondicherry
PONDICHERRY
605007
India 
Phone  04132619100  
Fax    
Email  josephine@aravind.org  
 
Source of Monetary or Material Support  
Aravind Eye Hospital, Pondicherry 605007 
 
Primary Sponsor  
Name  Aravind Eye Hospital  
Address  Aravind Eye Hospital Pondicherry Thavalakuppam Pondicherry 605007 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Josephine Christy  Aravind Eye Hospital  Room no 25, Department of Cornea, Thavalakuppam, Cuddalore road, Pondicherry, 605007
Pondicherry
PONDICHERRY 
04132619100

pdy.patientcare@aravind.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-AEH-P  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H160||Corneal ulcer,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional corneal scrpaing  Under topical anaesthesia, a scraping blade will be used to obtain corneal samples for - a)Smear examination : Gram & KOH stain b) Culture in blood agar c)Culture in potato dextrose agar 
Intervention  Using corneal impression membrane for obtaining material for diagnostic investigations   Under topical anaesthesia, corneal impression membrane will be used to obtain samples for - a)Smear examination : Gram & KOH stain b) Culture in Brain heart infusion broth c)For PCR  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Suspicion of Fungal Keratitis and
Undergoing routine corneal scraping for diagnostic purposes
 
 
ExclusionCriteria 
Details  Suspected Viral, Acanthamoeba, Mixed Keratitis cases
Microbial Keratitis in both eyes
Perforated ulcer
Small ulcer of less than 3 mm 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To demonstrate at least 65% sensitivity of CIM in detecting fungal organisms, thereby proving a non-inferiority of CIM to conventional corneal scraping method.

To demonstrate that CIM collected specimens can be used for immediate identification of organisms by smear microscopy.
 
The microbiology positivity will be checked at Day 1, 3 days, 1 week and 2 weeks.  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Microbial keratitis remains a challenge to diagnose, with gold-standard culture often positive in <60% of cases. Moreover, smear microscopy positivity rates also suffer from low sensitivity. These poor outcomes are often attributed to very low pathogen levels within the collected samples, which are routinely collected by sharp instruments, such as a blade or needle.

 

Since May 2017, Corneal Impression Membranes (CIMs) have replaced these sharp instruments as the gold-standard, sampling tool at St Pauls Eye Hospital in Liverpool, UK, and are now being more broadly adopted across major corneal departments in the UK. In Liverpool, it has been shown through both experimental and clinical studies that the CIMs reliably provide better microbiological diagnostic rates than a sharp instrument and/or a swab for bacterial keratitis (in Liverpool, culture positivity increased from 19.4% for scraped samples to 65.2% for samples collected by CIM (total 3099 corneal samples))1.  The use of the CIM also results in a better patient experience compared to obtaining samples using a sharp instrument. In addition, it provides the opportunity to expand its usage among ophthalmic technicians in primary care centres.

 

Till date CIMs have not been evaluated in the Indian context, and the performance of CIMs in improving fungal culture positivity rates is not known, due to low fungal burden in the UK (<1% of the samples evaluated in Liverpool).

 

 

Hypothesis: CIMs will be non-inferior to conventional microbial keratitis sampling with a sharp instrument (current gold-standard) when evaluated by broth and solid culture.


Aim: To evaluate CIMs in comparison to conventional scrapes for microbiological reporting from infectious keratitis patients (fungal suspicion). The Primary comparison will be to culture. The Secondary output will be to compare to smear microscopy.

 

Objectives:

1.     To compare the culture positivity rate between conventional (Scraping) method and CIM

2.     To compare the smear positivity rate between conventional (Scraping) method and CIM

3.     To evaluate the efficacy of CIMs with respect to fungal keratitis

 

 

Type of study:

Prospective PILOT study for evaluation of an alternative sample collection method for microbial keratitis sampling 


 
Close